Richard A. Larson to Antigens, Differentiation, B-Lymphocyte
This is a "connection" page, showing publications Richard A. Larson has written about Antigens, Differentiation, B-Lymphocyte.
Connection Strength
0.108
-
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. J Clin Oncol. 2013 Mar 01; 31(7):923-9.
Score: 0.108